Ultralife Corporation
NASDAQ:ULBIElectrical Equipment & Parts
+$0.08 today
- Market cap
- $261.13M
- Beta
- 0.76
- P/E (TTM)
- -12.9
- EPS (TTM)
- -$0.49
Volume 0.10M
Average 0.05M
ULBI Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
Ultralife CorporationNASDAQ: ULBI
Operating Margin · Q1 FY2026 · quarter ended Mar 2026
Operating margin narrows to -0.5%
Operating margin was -0.5% in Q1 FY2026, down 7.2 pp from a year earlier. On a trailing-twelve-month basis it was 2.1%, down 3.3 pp year over year. Over 3 fiscal years it widened by 4.7 pp.
Context
- Operating margin widened in 2 of the last 3 fiscal years.
What to watch
Whether operating margin reaches the consensus estimate from 1 analysts of 10.2% for the fiscal year ending Dec 2026, up from 4.8% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -0.5%-6.2 pp QoQ
- Last fiscal yearDec 2025
- 4.8%-1.2 pp YoY
- LTMMar 2026
- 2.1%-3.3 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -7.2 pp | +5.1 pp | +12.2 pp |
| 1 year | -1.2 pp | +5.4 pp | +6.6 pp |
| 3 years | +4.7 pp | — | — |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 4.8%
- Year-over-year change
- -1.2pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.8% | -1.2pp |
| FY2024 | 2024-12-31 | 6.1% | +0.1pp |
| FY2023 | 2023-12-31 | 6.0% | +5.9pp |
| FY2022 | 2022-12-31 | 0.1% | +0.1pp |
| FY2021 | 2021-12-31 | 0.0% | — |
Operating Margin vs competitors
How ULBI compares with its peers on the latest reported figures
- ULBI's LTM Mar 2026 operating margin of 2.1% is the 3rd highest of the 6 companies compared; the peer median is -11.1%.
- Its year-over-year change of -3.3 pp is the 3rd highest of 6, against a peer median of -8.2 pp.
- Over three fiscal years its change of +4.7 pp compares with a peer median of -4.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 25.4% | +8.9 pp | +13.7 pp | |
| LTM Mar 2026 | 23.0% | +11.9 pp | -25.1 pp | |
| LTM Mar 2026 | 2.1% | -3.3 pp | +4.7 pp | |
| LTM Mar 2026 | -11.1% | -8.2 pp | -4.9 pp | |
| LTM Mar 2026 | -769.0% | -276.7 pp | -2216.9 pp | |
| LTM Jan 2026 | -982.0% | -638.9 pp | +858.7 pp | |
| FY2026 | — | — | — | |
| Peer median (excluding ULBI) | -11.1% | -8.2 pp | -4.9 pp | |
Competitors are the stored peer set for ULBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 98.27M | 131.84M | 158.64M | 164.46M | 191.16M |
| Cost of Revenue | 73.63M | 102.44M | 119.44M | 122.14M | 146.66M |
| Gross Profit | 24.64M | 29.4M | 39.2M | 42.31M | 44.5M |
| Gross Margin | 25.1% | 22.3% | 24.7% | 25.7% | 23.3% |
| Research & Development | 6.83M | 7.08M | 7.53M | 8.27M | 9M |
| Selling, General & Admin | 17.78M | 22.19M | 22.19M | 24.08M | 26.28M |
| Operating Expenses | 24.61M | 29.27M | 29.73M | 32.35M | 35.28M |
| Depreciation & Amortization | 3.54M | 4.46M | 3.91M | 4.16M | 5.5M |
| EBITDA | 3.63M | 4.96M | 15.04M | 14.4M | 1.05M |
| EBITDA Margin | 3.7% | 3.8% | 9.5% | 8.8% | 0.6% |
| Operating Income | 35K | 129K | 9.48M | 9.97M | 9.22M |
| Operating Margin | 0.0% | 0.1% | 6.0% | 6.1% | 4.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 242K | 951K | 2.02M | 1.94M | 3.95M |
| Other Income / Expenses | (186K) | (575K) | (358K) | (1.66M) | (17.62M) |
| Income Before Tax | (151K) | (446K) | 9.12M | 8.3M | (8.4M) |
| Pre-Tax Margin | -0.2% | -0.3% | 5.7% | 5.0% | -4.4% |
| Income Tax Expense | 79K | (326K) | 1.95M | 1.89M | (2.45M) |
| Net Income | (234K) | (119K) | 7.2M | 6.31M | (5.9M) |
| Net Margin | -0.2% | -0.1% | 4.5% | 3.8% | -3.1% |
| EPS (Basic) | (0.01) | (0.01) | 0.44 | 0.38 | (0.35) |
| EPS (Diluted) | (0.01) | (0.01) | 0.44 | 0.38 | (0.35) |
| Weighted Avg Shares | 16.04M | 16.13M | 16.36M | 16.56M | 16.64M |
| Weighted Avg Shares (Diluted) | 16.04M | 16.13M | 16.23M | 16.77M | 16.64M |
Ultralife Corporation
NASDAQ:ULBI
Intrinsic Alpha fair value
Locked
Current Price
$15.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.